Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 7,597 | 6,007 | 5,390 | 5,111 | 4,386 |
| Cost of Goods | 3,148 | 2,947 | 2,336 | 2,297 | 2,084 |
| Gross Profit | 4,449 | 3,061 | 3,054 | 2,814 | 2,303 |
| Operating Expenses | 4,803 | 4,027 | 3,145 | 3,744 | 3,077 |
| Operating Income | -206 | -20 | 245 | -633 | -690 |
| Other Income | -49 | 225 | -53 | -64 | 7 |
| Pre-tax Income | -256 | 205 | 192 | -697 | -683 |
| Income Tax | -88 | 88 | 103 | -287 | -299 |
| Net Income Continuous | -167 | 117 | 90 | -410 | -385 |
| Net Income | $-167 | $117 | $90 | $-410 | $-385 |
| EPS Basic Total Ops | -0.06 | 0.04 | 0.03 | -0.14 | -0.13 |
| EPS Basic Continuous Ops | -0.06 | 0.04 | 0.03 | -0.14 | -0.13 |
| EPS Diluted Total Ops | -0.06 | 0.04 | 0.03 | -0.14 | -0.13 |
| EPS Diluted Continuous Ops | -0.06 | 0.04 | 0.03 | -0.14 | -0.13 |
| EBITDA(a) | $243 | $398 | $648 | $-214 | $-271 |